1. Home
  2. HRTG vs CSTL Comparison

HRTG vs CSTL Comparison

Compare HRTG & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$26.50

Market Cap

670.9M

Sector

Finance

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$23.39

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRTG
CSTL
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
670.9M
722.8M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
HRTG
CSTL
Price
$26.50
$23.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$33.50
$45.50
AVG Volume (30 Days)
355.6K
334.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
214.43
N/A
EPS
1.19
N/A
Revenue
$847,330,000.00
$344,229,000.00
Revenue This Year
$7.50
$2.42
Revenue Next Year
$6.74
$12.69
P/E Ratio
$23.34
N/A
Revenue Growth
3.71
3.66
52 Week Low
$16.83
$14.59
52 Week High
$31.98
$44.28

Technical Indicators

Market Signals
Indicator
HRTG
CSTL
Relative Strength Index (RSI) 55.41 54.29
Support Level $25.28 $23.21
Resistance Level $27.73 $24.00
Average True Range (ATR) 1.04 0.96
MACD 0.07 -0.08
Stochastic Oscillator 56.37 43.07

Price Performance

Historical Comparison
HRTG
CSTL

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance across various states in the U.S. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. The company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, and South Carolina.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: